BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 5546191)

  • 21. Immunosuppression and neoplasia. I. A critical review of experimental carcinogenesis and the immunesurveillance theory.
    Gleichmann H; Gleichmann E
    Klin Wochenschr; 1973 Mar; 51(6):255-9 contd. PubMed ID: 4147391
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of corneal graft reaction by antilymphocyte serum. 3. Effect of pretreatment of donor animals.
    Smolin G; Hyndiuk RA
    Arch Ophthalmol; 1971 Apr; 85(4):451-4. PubMed ID: 4929072
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunologic response to transplantable specific antigens in experimental tumors].
    Porwit-Bóbr Z
    Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042
    [No Abstract]   [Full Text] [Related]  

  • 24. An in vitro test of the immunosuppressive activity of antilymphocyte serum.
    Möller G; Lundgren G; Balner H
    Transplantation; 1970 Feb; 9(2):166-8. PubMed ID: 4984355
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of Escherichia coli endotoxin on skin allografts in mice.
    Skopińska E; Oluwasanmi JO
    Folia Biol (Praha); 1972; 18(4):270-6. PubMed ID: 4559930
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of immunosuppression by heterologous anti-lymphocyte serum (ALS) and plasma (ALP).
    Jeejeebhoy HF; Rabbat AG; Vela-Martinez JM
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):132-7. PubMed ID: 4913082
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression of the development of primary antibacterial immunity by heterologous anti-lymphocyte serum.
    Réthy L; Padányi M
    Acta Vet Acad Sci Hung; 1969; 19(4):405-15. PubMed ID: 4909689
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased oncogenic effect of a low dose of methylcholanthrene in immunodepressed mice.
    Carbone G; Parmiani G
    Tumori; 1971; 57(4):225-31. PubMed ID: 5143481
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative studies on the effect of antilymphocyte serum (ALS) and of proteolytic inhibitors on the survival time of skin transplants in rabbits].
    Fidelski R; Niedworok J; Tchórzewski H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(2):231-5. PubMed ID: 4111657
    [No Abstract]   [Full Text] [Related]  

  • 30. Heterologous antilymphocyte serum (ALS) hastens the appearance of methylcholanthrene-induced tumours in mice.
    Rabbat AG; Jeejeebhoy HF
    Transplantation; 1970 Feb; 9(2):164-6. PubMed ID: 4905925
    [No Abstract]   [Full Text] [Related]  

  • 31. [Development of drug-induced tumors in mice depending on the activity of the immunocompetent systems of the body].
    Neĭman IM; Finogenova MA
    Patol Fiziol Eksp Ter; 1978; (2):26-9. PubMed ID: 673472
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR; Fahey KJ
    Adv Exp Med Biol; 1973; 29(0):411-7. PubMed ID: 4211985
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental lung transplantation. Immunosuppressive therapy].
    Morino F; Olivero S; Vezzosi E; Bezzi P; Ibba F; Gallingani R; Sanfelici G
    Minerva Med; 1969 Mar; 60(21):903-17. PubMed ID: 4888328
    [No Abstract]   [Full Text] [Related]  

  • 34. [Liver transplantation].
    Mikaeloff P
    Bull Soc Int Chir; 1967 Sep; 26(5):489-95. PubMed ID: 4913603
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunosuppressive properties of heterologous antilymphocyte sera (review of the literature)].
    Khundanov LL; Portnoĭ VF; Kipervasser EM; Shatalova IN
    Eksp Khir Anesteziol; 1969; 14(2):41-6. PubMed ID: 4391647
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological problems in organ transplantation (with reference to oncology)].
    Gazzera G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(9):599-614. PubMed ID: 4932115
    [No Abstract]   [Full Text] [Related]  

  • 37. Local effects of antilymphocyte serum.
    Halasz NA; Amonic R; Devin J; Miller S
    Transplant Proc; 1969 Mar; 1(1):442-4. PubMed ID: 4944257
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of immunosuppression in experimental bone transplants using 85Sr.
    Kollmer WE; Märkl R
    Int J Appl Radiat Isot; 1974 Jun; 25(6):284-5. PubMed ID: 4604450
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical use of antilymphocyte serum in organ and tissue allotransplantation (survey of the literature)].
    Korenevskaia VA; Shumakov VI
    Khirurgiia (Mosk); 1972 Feb; 49(2):127-31. PubMed ID: 4572233
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice.
    Simmons RL; Rios A; Ray PK; Lundgren G
    J Natl Cancer Inst; 1971 Nov; 47(5):1087-94. PubMed ID: 5123336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.